Literature DB >> 26090570

Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1.

Zhuoshen Zhao1, Ed Manser.   

Abstract

Cdc42 is a member of the Rho GTPase protein family that plays key roles in local F-actin organization through a number of kinase and non-kinase effector proteins. The myotonic dystrophy kinase-related Cdc42-binding kinases (MRCKs), and the RhoA binding coiled-coil containing kinases (ROCKs) are widely expressed members of the Dystrophia myotonica protein kinase (DMPK) family. The MRCK proteins are ∼190 kDa multi-domain proteins expressed in all cells and coordinate certain acto-myosin networks. Notably MRCK is a key regulator of myosin18A and myosin IIA/B, and through phosphorylation of their common regulatory light chains (MYL9 or MLC2) to promote actin stress fiber contractility. The MRCK kinases are regulated by Cdc42, which is required for cell polarity and directional migration; MRCK links to the acto-myosin complex through interaction with a coiled-coil containing adaptor proteins LRAP35a/b. The biological activities of MRCK in model organisms such as worms and flies confirm it as a myosin II activator. In mammalian cell culture MRCK can be critical for cancer cell migration and neurite outgrowth. We review the current literatures regarding MRCK and highlight the similarities and differences between MRCK and ROCK kinases.

Entities:  

Keywords:  Cdc42; Rho GTPase; acto-myosin; cell adhesion

Mesh:

Substances:

Year:  2015        PMID: 26090570      PMCID: PMC4601156          DOI: 10.1080/21541248.2014.1000699

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  92 in total

1.  Targeting and clustering citron to synapses.

Authors:  Wandong Zhang; Deanna L Benson
Journal:  Mol Cell Neurosci       Date:  2005-10-03       Impact factor: 4.314

2.  Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells.

Authors:  Andrea Murányi; Dmitry Derkach; Ferenc Erdodi; Andrea Kiss; Masaaki Ito; David J Hartshorne
Journal:  FEBS Lett       Date:  2005-11-09       Impact factor: 4.124

Review 3.  Coordinating Rho and Rac: the regulation of Rho GTPase signaling and cadherin junctions.

Authors:  Aparna Ratheesh; Rashmi Priya; Alpha S Yap
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

4.  The structure of dimeric ROCK I reveals the mechanism for ligand selectivity.

Authors:  Marc Jacobs; Koto Hayakawa; Lora Swenson; Steven Bellon; Mark Fleming; Paul Taslimi; John Doran
Journal:  J Biol Chem       Date:  2005-10-24       Impact factor: 5.157

Review 5.  Signaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation.

Authors:  Kensaku Mizuno
Journal:  Cell Signal       Date:  2012-11-12       Impact factor: 4.315

6.  Cross-talk between Rho-associated kinase and cyclic nucleotide-dependent kinase signaling pathways in the regulation of smooth muscle myosin light chain phosphatase.

Authors:  Michael E Grassie; Cindy Sutherland; Annegret Ulke-Lemée; Mona Chappellaz; Enikö Kiss; Michael P Walsh; Justin A MacDonald
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

Review 7.  Cycling around cell-cell adhesion with Rho GTPase regulators.

Authors:  Jessica McCormack; Natalie J Welsh; Vania M M Braga
Journal:  J Cell Sci       Date:  2013-01-15       Impact factor: 5.285

8.  Rap1 potentiates endothelial cell junctions by spatially controlling myosin II activity and actin organization.

Authors:  Koji Ando; Shigetomo Fukuhara; Takahiro Moriya; Yutaro Obara; Norimichi Nakahata; Naoki Mochizuki
Journal:  J Cell Biol       Date:  2013-09-09       Impact factor: 10.539

9.  Keratinocyte migration in the developing eyelid requires LIMK2.

Authors:  Dennis S Rice; Gwenn M Hansen; Feng Liu; Mike J Crist; Matthew M Newhouse; David Potter; Nianhua Xu; Alejandro Abuin; Peter J Vogel; Brian P Zambrowicz
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

10.  Structure of a highly conserved domain of Rock1 required for Shroom-mediated regulation of cell morphology.

Authors:  Swarna Mohan; Debamitra Das; Robert J Bauer; Annie Heroux; Jenna K Zalewski; Simone Heber; Atinuke M Dosunmu-Ogunbi; Michael A Trakselis; Jeffrey D Hildebrand; Andrew P Vandemark
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more
  29 in total

1.  Phosphoproteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier function.

Authors:  Ying Lin; Jacob M Wozniak; Neil J Grimsey; Sravan Girada; Anand Patwardhan; Olivia Molinar-Inglis; Thomas H Smith; John D Lapek; David J Gonzalez; JoAnn Trejo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

2.  Rho GTPases at the crossroad of signaling networks in mammals.

Authors:  Jean Claude Hervé; Nicolas Bourmeyster
Journal:  Small GTPases       Date:  2015-06-25

Review 3.  Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and Vascular Disease.

Authors:  Maria Grazia Lampugnani; Elisabetta Dejana; Costanza Giampietro
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-10-01       Impact factor: 10.005

4.  Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma.

Authors:  Alison M Kurimchak; Carlos Herrera-Montávez; Jennifer Brown; Katherine J Johnson; Valerie Sodi; Nishi Srivastava; Vikas Kumar; Safoora Deihimi; Shane O'Brien; Suraj Peri; Gina M Mantia-Smaldone; Angela Jain; Ryan M Winters; Kathy Q Cai; Jonathan Chernoff; Denise C Connolly; James S Duncan
Journal:  Sci Signal       Date:  2020-02-18       Impact factor: 8.192

Review 5.  Targeting the cytoskeleton against metastatic dissemination.

Authors:  Carmen Ruggiero; Enzo Lalli
Journal:  Cancer Metastasis Rev       Date:  2021-01-20       Impact factor: 9.264

6.  DDX17 promotes the growth and metastasis of lung adenocarcinoma.

Authors:  Xiaohui Liu; Lu Li; Chengjie Geng; Shiyuan Wen; Cuiqiong Zhang; Chunmiao Deng; Xuejuan Gao; Gong Zhang; Qing-Yu He; Langxia Liu
Journal:  Cell Death Discov       Date:  2022-10-22

7.  MRCK-1 Drives Apical Constriction in C. elegans by Linking Developmental Patterning to Force Generation.

Authors:  Daniel J Marston; Christopher D Higgins; Kimberly A Peters; Timothy D Cupp; Daniel J Dickinson; Ariel M Pani; Regan P Moore; Amanda H Cox; Daniel P Kiehart; Bob Goldstein
Journal:  Curr Biol       Date:  2016-07-21       Impact factor: 10.834

8.  Differential cellular responses to adhesive interactions with galectin-8- and fibronectin-coated substrates.

Authors:  Wenhong Li; Ana Sancho; Wen-Lu Chung; Yaron Vinik; Jürgen Groll; Yehiel Zick; Ohad Medalia; Alexander D Bershadsky; Benjamin Geiger
Journal:  J Cell Sci       Date:  2021-04-27       Impact factor: 5.285

9.  Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer.

Authors:  Mathieu Unbekandt; Simone Belshaw; Justin Bower; Maeve Clarke; Jacqueline Cordes; Diane Crighton; Daniel R Croft; Martin J Drysdale; Mathew J Garnett; Kathryn Gill; Christopher Gray; David A Greenhalgh; James A M Hall; Jennifer Konczal; Sergio Lilla; Duncan McArthur; Patricia McConnell; Laura McDonald; Lynn McGarry; Heather McKinnon; Carol McMenemy; Mokdad Mezna; Nicolas A Morrice; June Munro; Gregory Naylor; Nicola Rath; Alexander W Schüttelkopf; Mairi Sime; Michael F Olson
Journal:  Cancer Res       Date:  2018-01-30       Impact factor: 12.701

10.  E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer.

Authors:  Ilirjana Bajrami; Rebecca Marlow; Marieke van de Ven; Rachel Brough; Helen N Pemberton; Jessica Frankum; Feifei Song; Rumana Rafiq; Asha Konde; Dragomir B Krastev; Malini Menon; James Campbell; Aditi Gulati; Rahul Kumar; Stephen J Pettitt; Mark D Gurden; Marta Llorca Cardenosa; Irene Chong; Patrycja Gazinska; Fredrik Wallberg; Elinor J Sawyer; Lesley-Ann Martin; Mitch Dowsett; Spiros Linardopoulos; Rachael Natrajan; Colm J Ryan; Patrick W B Derksen; Jos Jonkers; Andrew N J Tutt; Alan Ashworth; Christopher J Lord
Journal:  Cancer Discov       Date:  2018-04       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.